Agios Pharma's total assets for Q4 2024 were $1.66B, a decrease of -7.18% from the previous quarter. AGIO total liabilities were $122.24M for the fiscal quarter, a -25.97% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.